Simon L Conti, MD
Urology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Conti’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A113515 · Current
Licensed to practise in California · since 2010 · expires 2028-08-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$73,688
Medicare paid this office $73,688 for 287 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Crushing of stone of ureter with insertion of stent using an endoscope | 46 | $21,244 | $379 |
| Return visit (30+ min) | 92 | $9,170 | $83 |
| Return visit (30+ min) | 54 | $6,807 | $115 |
| Insertion of stent in ureter using an endoscope | 33 | $5,975 | $127 |
| New patient visit (45+ min) | 47 | $5,024 | $107 |
See all 9 services
| Crushing of stone of ureter with insertion of stent using an endoscope | 46 | $21,244 | $379 |
| Return visit (30+ min) | 92 | $9,170 | $83 |
| Return visit (30+ min) | 54 | $6,807 | $115 |
| Insertion of stent in ureter using an endoscope | 33 | $5,975 | $127 |
| New patient visit (45+ min) | 47 | $5,024 | $107 |
| Diagnostic exam of bladder and urethra using an endoscope | 39 | $2,695 | $69 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 13 | $1,611 | $124 |
| Short return visit (20+ min) | 17 | $1,011 | $59 |
| New patient visit (30+ min) | 11 | $734 | $67 |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
Who their Medicare patients are
287 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 13% · Women 44% · Also on Medicaid 23% · Health risk score 1.60. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 67% · Chronic kidney disease 34% · Coronary heart disease 30% · Diabetes 26% · Cancer 23% · Atrial fibrillation 22% · Depression 20% · Heart failure 18% · COPD 12% · Dementia 12% · Stroke 8%.
The office billed $1,855,816, Medicare allowed $95,906 and paid $73,688; for 491 services of 34 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 287 | 491 | 73 | 1.60 | $1,855,816 | $73,688 |
| 2023 | 276 | 513 | 73 | 1.90 | $2,345,059 | $82,126 |
| 2022 | 253 | 494 | 71 | 1.73 | $2,322,447 | $75,569 |
| 2021 | 270 | 521 | 73 | 1.68 | $1,946,136 | $73,555 |
| 2020 | 257 | 501 | 72 | 1.60 | $1,962,841 | $77,019 |
| 2019 | 250 | 441 | 71 | 1.71 | $639,941 | $68,382 |
| 2018 | 230 | 458 | 71 | 1.80 | $696,149 | $73,544 |
| 2017 | 194 | 389 | 71 | 1.91 | $761,557 | $66,730 |
| 2016 | 130 | 303 | 72 | 1.90 | $516,679 | $46,004 |
| 2015 | 80 | 143 | 70 | 1.52 | $253,508 | $22,279 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Crushing of stone of ureter with insertion of stent using an endoscope | 42 | $17,350 | $377 |
| Return visit (30+ min) | 103 | $9,134 | $77 |
| Insertion of stent in ureter using an endoscope | 41 | $9,018 | $133 |
| New patient visit (45+ min) | 61 | $7,303 | $120 |
| Long return visit (40+ min) | 30 | $3,723 | $124 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 16 | $1,979 | $124 |
| Diagnostic exam of bladder and urethra using an endoscope | 28 | $1,656 | $59 |
| New patient visit (30+ min) | 20 | $1,363 | $68 |
| Short return visit (20+ min) | 13 | $793 | $57 |
| Imaging of urinary tract following injection of a contrast agent | 25 | $657 | $23 |
2022: 11 services
| Crushing of stone of ureter with insertion of stent using an endoscope | 47 | $20,016 | $357 |
| Insertion of stent in ureter using an endoscope | 44 | $8,626 | $131 |
| Return visit (30+ min) | 96 | $8,475 | $78 |
| New patient visit (45+ min) | 53 | $6,227 | $117 |
| Removal or manipulation of stone in ureter or kidney using an endoscope | 11 | $2,797 | $254 |
| Long return visit (40+ min) | 23 | $2,707 | $118 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 13 | $1,698 | $131 |
| Diagnostic exam of bladder and urethra using an endoscope | 24 | $1,538 | $62 |
| Short return visit (20+ min) | 27 | $1,521 | $54 |
| New patient visit (30+ min) | 16 | $1,140 | $71 |
| Imaging of urinary tract following injection of a contrast agent | 14 | $366 | $23 |
2021: 10 services
| Crushing of stone of ureter with insertion of stent using an endoscope | 38 | $15,475 | $387 |
| Return visit (30+ min) | 90 | $8,488 | $81 |
| New patient visit (45+ min) | 64 | $7,660 | $120 |
| Insertion of stent in ureter using an endoscope | 45 | $7,482 | $123 |
| Long return visit (40+ min) | 24 | $3,251 | $130 |
| Diagnostic exam of bladder and urethra using an endoscope | 31 | $2,438 | $74 |
| New patient visit (60+ min) | 15 | $2,338 | $156 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 16 | $2,178 | $136 |
| Short return visit (20+ min) | 32 | $1,902 | $58 |
| Imaging of urinary tract following injection of a contrast agent | 16 | $420 | $23 |
2020: 11 services
| Crushing of stone of ureter with insertion of stent using an endoscope | 52 | $21,780 | $369 |
| Insertion of stent in ureter using an endoscope | 46 | $7,939 | $120 |
| New patient visit (45+ min) | 59 | $6,765 | $115 |
| Return visit (30+ min) | 79 | $5,823 | $67 |
| Removal or manipulation of stone in ureter or kidney using an endoscope | 15 | $3,018 | $201 |
| Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope | 11 | $2,765 | $251 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 16 | $2,487 | $138 |
| Diagnostic exam of bladder and urethra using an endoscope | 25 | $1,854 | $71 |
| Short return visit (20+ min) | 27 | $1,291 | $48 |
| Long return visit (40+ min) | 14 | $1,279 | $91 |
| Imaging of urinary tract following injection of a contrast agent | 13 | $337 | $24 |
2019: 8 services
| Crushing of stone of ureter with insertion of stent using an endoscope | 51 | $21,791 | $357 |
| New patient visit (45+ min) | 82 | $8,931 | $109 |
| Return visit (30+ min) | 89 | $6,958 | $66 |
| Insertion of stent in ureter using an endoscope | 34 | $6,397 | $145 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 12 | $1,672 | $139 |
| Diagnostic exam of bladder and urethra using an endoscope | 21 | $1,633 | $71 |
| Long return visit (40+ min) | 15 | $1,313 | $88 |
| Short return visit (20+ min) | 17 | $789 | $44 |
2018: 7 services
| Crushing of stone of ureter with insertion of stent using an endoscope | 48 | $21,280 | $373 |
| Return visit (30+ min) | 88 | $7,122 | $64 |
| New patient visit (45+ min) | 67 | $7,122 | $106 |
| Insertion of stent in ureter using an endoscope | 39 | $5,951 | $110 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 30 | $3,997 | $129 |
| Removal or manipulation of stone in ureter or kidney using an endoscope | 12 | $3,470 | $289 |
| Diagnostic exam of bladder and urethra using an endoscope | 27 | $2,537 | $75 |
2017: 7 services
| Crushing of stone of ureter with insertion of stent using an endoscope | 39 | $15,803 | $385 |
| New patient visit (45+ min) | 57 | $6,279 | $110 |
| Insertion of stent in ureter using an endoscope | 32 | $5,838 | $127 |
| Return visit (30+ min) | 76 | $5,774 | $68 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 24 | $3,230 | $129 |
| Diagnostic exam of bladder and urethra using an endoscope | 16 | $1,509 | $89 |
| Short return visit (20+ min) | 19 | $822 | $41 |
2016: 7 services
| Crushing of stone of ureter with insertion of stent using an endoscope | 24 | $11,061 | $369 |
| New patient visit (45+ min) | 49 | $5,166 | $105 |
| Return visit (30+ min) | 44 | $4,284 | $65 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 23 | $2,920 | $122 |
| Insertion of stent in ureter using an endoscope | 23 | $2,605 | $90 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $1,531 | $109 |
| Short return visit (20+ min) | 16 | $776 | $41 |
2015: 4 services
| Crushing of stone of ureter with insertion of stent using an endoscope | 11 | $5,405 | $416 |
| New patient visit (45+ min) | 40 | $4,516 | $113 |
| Insertion of stent in ureter using an endoscope | 11 | $1,833 | $141 |
| Return visit (30+ min) | 24 | $1,687 | $70 |
Medicaid work
$1,042 in 2024
Medicaid paid $1,042 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 12 | $1,042 |
| 2024 | 12 | 1 | 12 | $1,042 |
| 2023 | 27 | 2 | 15 | $2,060 |
| 2022 | 26 | 2 | 14 | $1,640 |
| 2019 | 12 | 1 | 12 | $529 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 15 | $1,538 |
| Return visit (30+ min) | 12 | $522 |
2022
| New patient visit (45+ min) | 14 | $1,034 |
| Return visit (30+ min) | 12 | $606 |
2019
| Return visit (30+ min) | 12 | $529 |
Drugs they prescribed that Part D paid
$25,196
Pharmacies billed $25,196 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
316 generic and fewer than 11 brand-name prescriptions · $25,196 in drug cost · 64 antibiotic prescriptions to 32 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Potassium Citrate Er | 40 | $3,243 | $81 |
| Estradiol | 21 | $1,559 | $74 |
| Tamsulosin | 110 | $1,356 | $12 |
| Finasteride | 23 | $388 | $17 |
| Cephalexin | 44 | $218 | $5 |
See all 7 drugs
| Potassium Citrate Er | 40 | $3,243 | $81 |
| Estradiol | 21 | $1,559 | $74 |
| Tamsulosin | 110 | $1,356 | $12 |
| Finasteride | 23 | $388 | $17 |
| Cephalexin | 44 | $218 | $5 |
| Alfuzosin Hcl Er | 13 | $81 | $6 |
| Ciprofloxacin | 11 | $38 | $3 |
Year by year
| 2024 | 330 | 104 | None | None | $25,196 |
| 2023 | 364 | 115 | None | 12% | $46,096 |
| 2022 | 396 | 114 | None | None | $28,691 |
| 2021 | 358 | 105 | None | None | $24,497 |
| 2020 | 254 | 96 | None | 10% | $22,839 |
| 2019 | 295 | 95 | 4% (11) | 14% | $18,159 |
| 2018 | 353 | 103 | 3% (12) | None | $18,076 |
| 2017 | 288 | 104 | None | None | $10,738 |
| 2016 | 172 | 63 | 6% (11) | None | $8,503 |
| 2015 | 100 | 52 | 23% (23) | None | $2,612 |
| 2014 | 244 | 57 | 12% (30) | 16% | $11,349 |
| 2013 | 92 | 59 | 33% (30) | 18% | $3,165 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Myrbetriq | 26 | $23,721 | $912 |
| Flomax | 15 | $7,233 | $482 |
| Potassium Citrate Er | 40 | $5,011 | $125 |
| Tamsulosin | 122 | $2,548 | $21 |
| Cephalexin | 49 | $1,068 | $22 |
| Finasteride | 19 | $358 | $19 |
| Amoxicillin-Clavulanate Potass | 11 | $129 | $12 |
2022: 8 drugs
| Myrbetriq | 20 | $11,472 | $574 |
| Flomax | 17 | $6,057 | $356 |
| Potassium Citrate Er | 50 | $5,194 | $104 |
| Tamsulosin | 92 | $1,501 | $16 |
| Cephalexin | 90 | $913 | $10 |
| Finasteride | 26 | $300 | $12 |
| Alfuzosin Hcl Er | 12 | $181 | $15 |
| Ciprofloxacin | 17 | $117 | $7 |
2021: 7 drugs
| Myrbetriq | 22 | $8,953 | $407 |
| Potassium Citrate Er | 57 | $6,699 | $118 |
| Tamsulosin | 97 | $1,610 | $17 |
| Cephalexin | 62 | $532 | $9 |
| Finasteride | 17 | $239 | $14 |
| Alfuzosin Hcl Er | 11 | $145 | $13 |
| Ciprofloxacin | 22 | $113 | $5 |
2020: 6 drugs
| Myrbetriq | 18 | $9,519 | $529 |
| Potassium Citrate Er | 42 | $6,849 | $163 |
| Tamsulosin | 43 | $719 | $17 |
| Cephalexin | 60 | $454 | $8 |
| Finasteride | 14 | $116 | $8 |
| Ciprofloxacin | 12 | $44 | $4 |
2019: 7 drugs
| Potassium Citrate Er | 55 | $9,689 | $176 |
| Tamsulosin | 57 | $1,217 | $21 |
| Cephalexin | 55 | $575 | $10 |
| Oxybutynin Chloride Er | 16 | $435 | $27 |
| Finasteride | 25 | $296 | $12 |
| Chlorthalidone | 11 | $143 | $13 |
| Levofloxacin | 14 | $101 | $7 |
2018: 7 drugs
| Potassium Citrate Er | 55 | $8,916 | $162 |
| Tamsulosin | 104 | $1,471 | $14 |
| Finasteride | 33 | $464 | $14 |
| Cephalexin | 50 | $446 | $9 |
| Oxybutynin Chloride Er | 13 | $353 | $27 |
| Ciprofloxacin | 12 | $82 | $7 |
| Levofloxacin | 11 | $78 | $7 |
2017: 8 drugs
| Potassium Citrate Er | 26 | $2,901 | $112 |
| Tamsulosin | 72 | $977 | $14 |
| Oxybutynin Chloride Er | 22 | $598 | $27 |
| Finasteride | 18 | $233 | $13 |
| Amoxicillin-Clavulanate Potass | 12 | $197 | $16 |
| Cephalexin | 31 | $143 | $5 |
| Sulfamethoxazole-Trimethoprim | 17 | $105 | $6 |
| Ciprofloxacin | 16 | $81 | $5 |
2016: 5 drugs
| Vesicare | 13 | $3,814 | $293 |
| Tamsulosin | 27 | $383 | $14 |
| Finasteride | 19 | $234 | $12 |
| Ciprofloxacin | 19 | $92 | $5 |
| Cephalexin | 19 | $91 | $5 |
2015: 3 drugs
| Hydrocodone-Acetaminophen | 22 | $401 | $18 |
| Tamsulosin | 18 | $287 | $16 |
| Ciprofloxacin | 24 | $165 | $7 |
2014: 5 drugs
| Avodart | 39 | $7,725 | $198 |
| Tamsulosin | 113 | $1,750 | $15 |
| Oxybutynin Chloride Er | 30 | $1,291 | $43 |
| Finasteride | 22 | $218 | $10 |
| Hydrocodone-Acetaminophen | 21 | $181 | $9 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 21 | $169 | $8 |
Money from drug and device companies
$3,562 in 2025
| 2025 | 2 | 3 | $3,520 | $3,562 |
| 2024 | 2 | 2 | None | $416 |
| 2022 | 1 | 2 | None | $35 |
| 2021 | 2 | 6 | $9,200 | $9,382 |
| 2019 | 1 | 3 | $1,200 | $1,200 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 3 published payments
| Ethicon | Travel · 2025-10-14 | Monarch Platform | $25 |
| Ethicon | Consulting · 2025-10-14 | Monarch Platform | $3,520 |
| Ambu | Meals · 2025-01-27 | None | $18 |
See earlier years (2024, 2022, 2021, 2019)
2024: $416
| Calyxo | Cvac Aspiration System | $267 | 1 payment
|
| Medical Device Business Services | None | $150 | 1 payment
|
2022: $35
| Boston Scientific | 8/10 Dilator/Sheath Set | $35 | 2 payments
|
2021: $9,382
| Ethicon | Monarch Platform | $9,291 | 5 payments
|
| Uromedica | Proact | $91 | 1 payment
|
2019: $1,200
| Intuitive Surgical | Da Vinci Surgical System | $1,200 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1679708705
- Licence
- CA A113515California A113515: Current · expires 2028-08-31
- Trained
- University of California, San Francisco School of Medicine, 2009
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Urology (208800000X); Surgery (208600000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2009-05-19
- NPI last updated
- 2024-03-13
- NPI record certified
- 2024-03-13
This is when the NPI record was last certified, not a medical board exam.